Details for New Drug Application (NDA): 203880
✉ Email this page to a colleague
NDA 203880 describes CYCLOSPORINE, which is a drug marketed by Apotex, Dr Reddys Labs Sa, Ivax Sub Teva Pharms, Onesource Specialty, Qilu, Sandoz, Amneal, Deva Holding As, Jiangsu Anbison, Mylan, Saptalis Pharms, Teva Pharms Usa Inc, Twi Pharms, Hikma, Padagis Us, Abbvie, Pharm Assoc, and Pharmobedient Cnsltg, and is included in twenty-two NDAs. It is available from ten suppliers. Additional details are available on the CYCLOSPORINE profile page.
The generic ingredient in CYCLOSPORINE is cyclosporine. There are eighteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
The generic ingredient in CYCLOSPORINE is cyclosporine. There are eighteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
Summary for 203880
| Tradename: | CYCLOSPORINE |
| Applicant: | Teva Pharms Usa Inc |
| Ingredient: | cyclosporine |
| Patents: | 0 |
Pharmacology for NDA: 203880
| Mechanism of Action | Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for 203880
Suppliers and Packaging for NDA: 203880
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CYCLOSPORINE | cyclosporine | EMULSION;OPHTHALMIC | 203880 | ANDA | Teva Pharmaceuticals, Inc. | 0480-4076 | 0480-4076-30 | 6 POUCH in 1 CARTON (0480-4076-30) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .4 mL in 1 VIAL, SINGLE-DOSE |
| CYCLOSPORINE | cyclosporine | EMULSION;OPHTHALMIC | 203880 | ANDA | Teva Pharmaceuticals, Inc. | 0480-4076 | 0480-4076-60 | 12 POUCH in 1 CARTON (0480-4076-60) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .4 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | EMULSION;OPHTHALMIC | Strength | 0.05% | ||||
| Approval Date: | Dec 14, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
